Prot #M10-880: A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Inactive Non-infectious Intermediate-, Posterior-, or Pan-uveitis

Project: Research project

Project Details

StatusFinished
Effective start/end date3/26/13 → 3/26/16

Funding

  • AbbVie Inc. (Prot #M10-880)